AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
Aug 6, 2013
30339_dirs_2013-08-06_ebcec6e8-f4a3-464e-b295-ac4abce510e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-05-16
Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-16 | Common Stock | G | 6000.0000 | $0.0000 | Disposed | 497168.4076 | Direct |
| 2013-07-08 | Common Stock | G | 1000.0000 | $0.0000 | Disposed | 524432.4076 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1335.6398 | Indirect |
| Common Stock | 20616.1248 | Indirect |
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27